News
OTIC
--
0.00%
--
Otonomy (OTIC) Investor Presentation - Slideshow
The following slide deck was published by Otonomy, Inc. in conjunction with this event.
Seekingalpha · 4d ago
What Kind Of Shareholders Hold The Majority In Otonomy, Inc.'s (NASDAQ:OTIC) Shares?
If you want to know who really controls Otonomy, Inc. (NASDAQ:OTIC), then you'll have to look at the makeup of its...
Simply Wall St. · 09/15 13:52
Are Options Traders Betting on a Big Move in Otonomy (OTIC) Stock?
Investors need to pay close attention to Otonomy (OTIC) stock based on the movements in the options market lately.
Zacks · 09/10 13:41
Otonomy to Participate in Four Upcoming Investor Conferences
SAN DIEGO, Sept. 02, 2020 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced that management is scheduled to participate in four upcoming virtual investor conferences. * Citi’s 15th Annual
GlobeNewswire · 09/02 12:30
The Daily Biotech Pulse: Pfizer-BioNTech Vaccine Data, Sorrento To Buy R&D Partner, Kymera IPO
  Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 20)
Benzinga · 08/21 11:43
Healthcare - Top 5 Gainers / Losers
Gainers: Aduro Biotech (ADRO) +20%. Otonomy (OTIC) +14%. BeyondSpring (BYSI) +13%. Verrica Pharmaceuticals (VRCA) +13%. STRATA Skin Sciences (SSKN) +11%.Losers: Poseida Therapeutics (PSTX) -30%. Acer Therapeutics (ACER) -20%. Biofrontera (BFRA) -15%. Unity Biotechnology
Seekingalpha · 08/18 15:02
SRNE, DBX among premarket gainers
MICT (NASDAQ:MICT) +95% on first major order for SmartCam. Forward (NASDAQ:FORD) +49% on acquiring Kablooe Design. iMedia Brands (NASDAQ:IMBI) +26% on Q2 r
Seeking Alpha - Article · 08/18 12:25
Billionaire Steven Cohen Pulls the Trigger on These 3 Penny Stocks
There are two sides to every coin. For penny stocks, or tickers that trade for less than $5 per share, this rings especially true. As some of the most divisive names on the Street, they are either met with resounding praise or forceful discontent.Going beyond the argument that you get more for your money
TipRanks · 08/17 20:30
Otonomy +5%; Q2 earnings indicates advancing product pipeline
For Q2, Otonomy (OTIC +4.2%) product sales of $10K vs. $190K in year ago period; EPS of -$0.37 vs. -$0.38. GAAP operating expenses of $10.6M vs. $11.8M As
seekingalpha · 08/05 23:43
Otonomy (OTIC) Reports Q2 Loss, Lags Revenue Estimates
Otonomy (OTIC) delivered earnings and revenue surprises of -2.78% and -92.06%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 08/04 23:25
Otonomy Q2 EPS $(0.37) Beats $(0.39) Estimate, Sales $10.00K Miss $90.00K Estimate
Otonomy (NASDAQ:OTIC) reported quarterly losses of $(0.37) per share which beat the analyst consensus estimate of $(0.39) by 5.13 percent. This is a 2.63 percent increase over losses of $(0.38) per share from the same
Benzinga · 08/04 21:04
Otonomy Reports Second Quarter 2020 Financial Results and Provides Corporate Update
* Positive top-line results reported for Phase 1/2 trial of OTO-313 in tinnitus patients * Public offering completed for total gross proceeds of $69.1 million * Results from Phase 3 trial of OTIVIDEX® in Ménière’s disease expected in first quarter of 2021
GlobeNewswire · 08/04 20:22
Otonomy Announces Exclusive License Agreement with Kyorin for Novel Compound in OTO-6XX Hearing Loss Program, Otnomy to Make an Upfront Payment and Potential Milestone Payments
Benzinga · 08/03 11:43
Otonomy Announces Exclusive License Agreement with Kyorin for Novel Compound in OTO-6XX Hearing Loss Program
Compound has potential to benefit patients with severe hearing lossSAN DIEGO, Aug. 03, 2020 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced a
GlobeNewswire · 08/03 11:30
Otonomy to Report Second Quarter 2020 Financial Results and Provide Corporate Update
Webcast and Conference Call to be Held at 5 p.m. EDT on August 4, 2020SAN DIEGO, July 28, 2020 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announce
GlobeNewswire · 07/28 20:05
Stocks To Watch: Big Focus On Big Tech
Seeking Alpha · 07/25 12:26
The Daily Biotech Pulse: Midatech Shelves Sale Plan, G1 Therapeutics Out-Licenses, Entera Bio Jumps On Survey Results
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 22)
Benzinga · 07/23 12:25
Steven Cohen Homes in on Otonomy by Expanding Stake
GuruFocus.com · 07/15 18:15
Otonomy Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
SAN DIEGO, July 13, 2020 (GLOBE NEWSWIRE) -- Otonomy, Inc. (Nasdaq: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced the closing of its previously announced underwritten public offering
GlobeNewswire · 07/13 20:01
Otonomy (OTIC) Catches Eye: Stock Jumps 9.1%
Otonomy (OTIC) saw a big move last session, as its shares jumped more than 9% on the day, amid huge volumes.
Zacks · 07/13 13:08